HER2-Positive and Triple-Negative Breast Cancer | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in HER2-Positive and Triple-Negative Breast Cancer

Featuring perspectives from Dr Ian E Krop and Dr Priyanka Sharma, including the following topics:

Introduction: Educating Non-Breast Cancer Specialty Oncologists About HER2-Targeted Therapies – ASCO Genitourinary Cancers Symposium 2024 (0:00)

HER2-Positive Breast Cancer — Dr Krop (12:30)

Triple-Negative Breast Cancer — Dr Sharma (36:34)

CME information and select publications

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.